CompletedNCT04275284
Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children
Studying Pneumococcal meningitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Witwatersrand, South Africa
- Principal Investigator
- Shabir A Madhi, MD PhDUniversity of the Witwatersrand, South Africa
- Intervention
- PCV10(biological)
- Enrollment
- 600 target
- Eligibility
- 3-5 years · All sexes
- Timeline
- 2020 – 2022
Study locations (1)
- Chris Hani Baragwanath Academic Hospital - DST/NRF VPD RMPRU, Soweto, Gauteng, South Africa
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04275284 on ClinicalTrials.govOther trials for Pneumococcal meningitis
Additional recruiting or active studies for the same condition.